|
|
 |
|
| | |
| | | | |
organism-gene
|
|
PR:P00750 |
tissue-type plasminogen activator (human)
|
hPLAT
|
"A tissue-type plasminogen activator that is encoded in the genome of human." [PRO:DNx, UniProtKB:P00750]
|
|
|
|
|
|
|
| | | | |
| | |
organism-sequence
|
|
PR:P00750-1 |
tissue-type plasminogen activator isoform h1 (human)
|
hPLAT/iso:h1
|
"A tissue-type plasminogen activator (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:P00750-1." [PRO:DNx, UniProtKB:P00750]
|
|
|
|
|
|
|
| | | | |
| | |
organism-sequence
|
|
PR:P00750-2 |
tissue-type plasminogen activator isoform h2 (human)
|
hPLAT/iso:h2
|
"A tissue-type plasminogen activator (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:P00750-2." [PRO:DNx, UniProtKB:P00750]
|
|
|
|
|
|
|
| | | | |
| | |
organism-sequence
|
|
PR:P00750-3 |
tissue-type plasminogen activator isoform h3 (human)
|
hPLAT/iso:h3
|
"A tissue-type plasminogen activator (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:P00750-3." [PRO:DNx, UniProtKB:P00750]
|
|
|
|
|
|
|
| | | | |
| | |
organism-sequence
|
|
PR:P00750-4 |
tissue-type plasminogen activator isoform h4 (human)
|
hPLAT/iso:h4
|
"A tissue-type plasminogen activator (human) that is a translation product of some mRNA whose exon structure and start site selection renders it capable of giving rise to a protein with the amino acid sequence represented by UniProtKB:P00750-4." [PRO:DNx, UniProtKB:P00750]
|
|
|
|
|
|
|
| | | | |
| | |
organism-modification
|
|
PR:000051250 |
tissue-type plasminogen activator N-glycosylated 1 (human)
|
hPLAT/NGlyco:1
|
"A tissue-type plasminogen activator (human) that has been N-glycosylated at the residue equivalent to Asn-152 of the amino acid sequence represented by UniProtKB:P00750-1, in which the glycan structure is represented by GlyTouCan:G01769FS. Example: UniProtKB:P00750-1, Asn-152, MOD:00160~GNO:G01769FS." [GlyGen:P00750-1, PMID:2226797, PMID:2513186, PMID:8687384, PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | |
organism-modification
|
|
PR:000051251 |
tissue-type plasminogen activator N-glycosylated 2 (human)
|
hPLAT/NGlyco:2
|
"A tissue-type plasminogen activator (human) that has been N-glycosylated at the residue equivalent to Asn-152 of the amino acid sequence represented by UniProtKB:P00750-1, in which the glycan structure is represented by GlyTouCan:G09482NW. Example: UniProtKB:P00750-1, Asn-152, MOD:00160~GNO:G09482NW." [GlyGen:P00750-1, PMID:2226797, PMID:2513186, PMID:8687384, PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | |
organism-modification
|
|
PR:000051252 |
tissue-type plasminogen activator N-glycosylated 3 (human)
|
hPLAT/NGlyco:3
|
"A tissue-type plasminogen activator (human) that has been N-glycosylated at the residue equivalent to Asn-152 of the amino acid sequence represented by UniProtKB:P00750-1, in which the glycan structure is represented by GlyTouCan:G12398HZ. Example: UniProtKB:P00750-1, Asn-152, MOD:00160~GNO:G12398HZ." [GlyGen:P00750-1, PMID:2514791, PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | |
organism-modification
|
|
PR:000051253 |
tissue-type plasminogen activator N-glycosylated 4 (human)
|
hPLAT/NGlyco:4
|
"A tissue-type plasminogen activator (human) that has been N-glycosylated at the residue equivalent to Asn-152 of the amino acid sequence represented by UniProtKB:P00750-1, in which the glycan structure is represented by GlyTouCan:G13151XE. Example: UniProtKB:P00750-1, Asn-152, MOD:00160~GNO:G13151XE." [GlyGen:P00750-1, PMID:2226797, PMID:2513186, PMID:8687384, PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | |
organism-modification
|
|
PR:000051254 |
tissue-type plasminogen activator N-glycosylated 5 (human)
|
hPLAT/NGlyco:5
|
"A tissue-type plasminogen activator (human) that has been N-glycosylated at the residue equivalent to Asn-152 of the amino acid sequence represented by UniProtKB:P00750-1, in which the glycan structure is represented by GlyTouCan:G21415RL. Example: UniProtKB:P00750-1, Asn-152, MOD:00160~GNO:G21415RL." [GlyGen:P00750-1, PMID:2226797, PMID:2513186, PMID:8687384, PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | |
organism-modification
|
|
PR:000051255 |
tissue-type plasminogen activator N-glycosylated 6 (human)
|
hPLAT/NGlyco:6
|
"A tissue-type plasminogen activator (human) that has been N-glycosylated at the residue equivalent to Asn-152 of the amino acid sequence represented by UniProtKB:P00750-1, in which the glycan structure is represented by GlyTouCan:G24440EI. Example: UniProtKB:P00750-1, Asn-152, MOD:00160~GNO:G24440EI." [GlyGen:P00750-1, PMID:2226797, PMID:2513186, PMID:8687384, PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | |
organism-modification
|
|
PR:000051256 |
tissue-type plasminogen activator N-glycosylated 7 (human)
|
hPLAT/NGlyco:7
|
"A tissue-type plasminogen activator (human) that has been N-glycosylated at the residue equivalent to Asn-152 of the amino acid sequence represented by UniProtKB:P00750-1, in which the glycan structure is represented by GlyTouCan:G35808UX. Example: UniProtKB:P00750-1, Asn-152, MOD:00160~GNO:G35808UX." [GlyGen:P00750-1, PMID:2226797, PMID:2513186, PMID:8687384, PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | |
organism-modification
|
|
PR:000051257 |
tissue-type plasminogen activator N-glycosylated 8 (human)
|
hPLAT/NGlyco:8
|
"A tissue-type plasminogen activator (human) that has been N-glycosylated at the residue equivalent to Asn-152 of the amino acid sequence represented by UniProtKB:P00750-1, in which the glycan structure is represented by GlyTouCan:G40702WU. Example: UniProtKB:P00750-1, Asn-152, MOD:00160~GNO:G40702WU." [GlyGen:P00750-1, PMID:2226797, PMID:2513186, PMID:8687384, PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | |
organism-modification
|
|
PR:000051258 |
tissue-type plasminogen activator N-glycosylated 9 (human)
|
hPLAT/NGlyco:9
|
"A tissue-type plasminogen activator (human) that has been N-glycosylated at the residue equivalent to Asn-152 of the amino acid sequence represented by UniProtKB:P00750-1, in which the glycan structure is represented by GlyTouCan:G41304KE. Example: UniProtKB:P00750-1, Asn-152, MOD:00160~GNO:G41304KE." [GlyGen:P00750-1, PMID:2226797, PMID:2513186, PMID:8687384, PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | |
organism-modification
|
|
PR:000051259 |
tissue-type plasminogen activator N-glycosylated 10 (human)
|
hPLAT/NGlyco:10
|
"A tissue-type plasminogen activator (human) that has been N-glycosylated at the residue equivalent to Asn-152 of the amino acid sequence represented by UniProtKB:P00750-1, in which the glycan structure is represented by GlyTouCan:G44533KV. Example: UniProtKB:P00750-1, Asn-152, MOD:00160~GNO:G44533KV." [GlyGen:P00750-1, PMID:2226797, PMID:2513186, PMID:8687384, PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | |
organism-modification
|
|
PR:000051260 |
tissue-type plasminogen activator N-glycosylated 11 (human)
|
hPLAT/NGlyco:11
|
"A tissue-type plasminogen activator (human) that has been N-glycosylated at the residue equivalent to Asn-152 of the amino acid sequence represented by UniProtKB:P00750-1, in which the glycan structure is represented by GlyTouCan:G44842OK. Example: UniProtKB:P00750-1, Asn-152, MOD:00160~GNO:G44842OK." [GlyGen:P00750-1, PMID:2514791, PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | |
organism-modification
|
|
PR:000051261 |
tissue-type plasminogen activator N-glycosylated 12 (human)
|
hPLAT/NGlyco:12
|
"A tissue-type plasminogen activator (human) that has been N-glycosylated at the residue equivalent to Asn-152 of the amino acid sequence represented by UniProtKB:P00750-1, in which the glycan structure is represented by GlyTouCan:G48848IF. Example: UniProtKB:P00750-1, Asn-152, MOD:00160~GNO:G48848IF." [GlyGen:P00750-1, PMID:2226797, PMID:2513186, PMID:8687384, PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | |
organism-modification
|
|
PR:000051262 |
tissue-type plasminogen activator N-glycosylated 13 (human)
|
hPLAT/NGlyco:13
|
"A tissue-type plasminogen activator (human) that has been N-glycosylated at the residue equivalent to Asn-152 of the amino acid sequence represented by UniProtKB:P00750-1, in which the glycan structure is represented by GlyTouCan:G55220VL. Example: UniProtKB:P00750-1, Asn-152, MOD:00160~GNO:G55220VL." [GlyGen:P00750-1, PMID:2514791, PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | |
organism-modification
|
|
PR:000051263 |
tissue-type plasminogen activator N-glycosylated 14 (human)
|
hPLAT/NGlyco:14
|
"A tissue-type plasminogen activator (human) that has been N-glycosylated at the residue equivalent to Asn-152 of the amino acid sequence represented by UniProtKB:P00750-1, in which the glycan structure is represented by GlyTouCan:G68668TB. Example: UniProtKB:P00750-1, Asn-152, MOD:00160~GNO:G68668TB." [GlyGen:P00750-1, PMID:2226797, PMID:2513186, PMID:8687384, PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | |
organism-modification
|
|
PR:000051264 |
tissue-type plasminogen activator N-glycosylated 15 (human)
|
hPLAT/NGlyco:15
|
"A tissue-type plasminogen activator (human) that has been N-glycosylated at the residue equivalent to Asn-152 of the amino acid sequence represented by UniProtKB:P00750-1, in which the glycan structure is represented by GlyTouCan:G68758PE. Example: UniProtKB:P00750-1, Asn-152, MOD:00160~GNO:G68758PE." [GlyGen:P00750-1, PMID:2226797, PMID:2513186, PMID:8687384, PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | |
organism-modification
|
|
PR:000051265 |
tissue-type plasminogen activator N-glycosylated 16 (human)
|
hPLAT/NGlyco:16
|
"A tissue-type plasminogen activator (human) that has been N-glycosylated at the residue equivalent to Asn-152 of the amino acid sequence represented by UniProtKB:P00750-1, in which the glycan structure is represented by GlyTouCan:G77038WW. Example: UniProtKB:P00750-1, Asn-152, MOD:00160~GNO:G77038WW." [GlyGen:P00750-1, PMID:2226797, PMID:2513186, PMID:8687384, PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | |
organism-modification
|
|
PR:000051266 |
tissue-type plasminogen activator N-glycosylated 17 (human)
|
hPLAT/NGlyco:17
|
"A tissue-type plasminogen activator (human) that has been N-glycosylated at the residue equivalent to Asn-152 of the amino acid sequence represented by UniProtKB:P00750-1, in which the glycan structure is represented by GlyTouCan:G77964WB. Example: UniProtKB:P00750-1, Asn-152, MOD:00160~GNO:G77964WB." [GlyGen:P00750-1, PMID:2514791, PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | |
organism-modification
|
|
PR:000051267 |
tissue-type plasminogen activator N-glycosylated 18 (human)
|
hPLAT/NGlyco:18
|
"A tissue-type plasminogen activator (human) that has been N-glycosylated at the residue equivalent to Asn-152 of the amino acid sequence represented by UniProtKB:P00750-1, in which the glycan structure is represented by GlyTouCan:G80966KZ. Example: UniProtKB:P00750-1, Asn-152, MOD:00160~GNO:G80966KZ." [GlyGen:P00750-1, PMID:2226797, PMID:2513186, PMID:8687384, PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | |
organism-modification
|
|
PR:000051268 |
tissue-type plasminogen activator N-glycosylated 19 (human)
|
hPLAT/NGlyco:19
|
"A tissue-type plasminogen activator (human) that has been N-glycosylated at the residue equivalent to Asn-152 of the amino acid sequence represented by UniProtKB:P00750-1, in which the glycan structure is represented by GlyTouCan:G83161QT. Example: UniProtKB:P00750-1, Asn-152, MOD:00160~GNO:G83161QT." [GlyGen:P00750-1, PMID:2226797, PMID:2513186, PMID:8687384, PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | |
organism-modification
|
|
PR:000051269 |
tissue-type plasminogen activator N-glycosylated 20 (human)
|
hPLAT/NGlyco:20
|
"A tissue-type plasminogen activator (human) that has been N-glycosylated at the residue equivalent to Asn-152 of the amino acid sequence represented by UniProtKB:P00750-1, in which the glycan structure is represented by GlyTouCan:G83461WR. Example: UniProtKB:P00750-1, Asn-152, MOD:00160~GNO:G83461WR." [GlyGen:P00750-1, PMID:2226797, PMID:2513186, PMID:8687384, PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | |
organism-modification
|
|
PR:000051270 |
tissue-type plasminogen activator N-glycosylated 21 (human)
|
hPLAT/NGlyco:21
|
"A tissue-type plasminogen activator (human) that has been N-glycosylated at the residue equivalent to Asn-152 of the amino acid sequence represented by UniProtKB:P00750-1, in which the glycan structure is represented by GlyTouCan:G85542KD. Example: UniProtKB:P00750-1, Asn-152, MOD:00160~GNO:G85542KD." [GlyGen:P00750-1, PMID:2226797, PMID:2513186, PMID:8687384, PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | |
organism-modification
|
|
PR:000051271 |
tissue-type plasminogen activator N-glycosylated 22 (human)
|
hPLAT/NGlyco:22
|
"A tissue-type plasminogen activator (human) that has been N-glycosylated at the residue equivalent to Asn-152 of the amino acid sequence represented by UniProtKB:P00750-1, in which the glycan structure is represented by GlyTouCan:G88417ED. Example: UniProtKB:P00750-1, Asn-152, MOD:00160~GNO:G88417ED." [GlyGen:P00750-1, PMID:2226797, PMID:2513186, PMID:8687384, PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | |
organism-modification
|
|
PR:000051272 |
tissue-type plasminogen activator N-glycosylated 23 (human)
|
hPLAT/NGlyco:23
|
"A tissue-type plasminogen activator (human) that has been N-glycosylated at the residue equivalent to Asn-152 of the amino acid sequence represented by UniProtKB:P00750-1, in which the glycan structure is represented by GlyTouCan:G88461FF. Example: UniProtKB:P00750-1, Asn-152, MOD:00160~GNO:G88461FF." [GlyGen:P00750-1, PMID:2226797, PMID:2513186, PMID:8687384, PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | |
organism-modification
|
|
PR:000051273 |
tissue-type plasminogen activator N-glycosylated 24 (human)
|
hPLAT/NGlyco:24
|
"A tissue-type plasminogen activator (human) that has been N-glycosylated at the residue equivalent to Asn-152 of the amino acid sequence represented by UniProtKB:P00750-1, in which the glycan structure is represented by GlyTouCan:G92570PJ. Example: UniProtKB:P00750-1, Asn-152, MOD:00160~GNO:G92570PJ." [GlyGen:P00750-1, PMID:2226797, PMID:2513186, PMID:8687384, PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | |
organism-modification
|
|
PR:000051274 |
tissue-type plasminogen activator N-glycosylated 25 (human)
|
hPLAT/NGlyco:25
|
"A tissue-type plasminogen activator (human) that has been N-glycosylated at the residue equivalent to Asn-152 of the amino acid sequence represented by UniProtKB:P00750-1, in which the glycan structure is represented by GlyTouCan:G94141FZ. Example: UniProtKB:P00750-1, Asn-152, MOD:00160~GNO:G94141FZ." [GlyGen:P00750-1, PMID:2226797, PMID:2513186, PMID:8687384, PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | |
organism-modification
|
|
PR:000051275 |
tissue-type plasminogen activator N-glycosylated 26 (human)
|
hPLAT/NGlyco:26
|
"A tissue-type plasminogen activator (human) that has been N-glycosylated at the residue equivalent to Asn-152 of the amino acid sequence represented by UniProtKB:P00750-1, in which the glycan structure is represented by GlyTouCan:G95861KV. Example: UniProtKB:P00750-1, Asn-152, MOD:00160~GNO:G95861KV." [GlyGen:P00750-1, PMID:2226797, PMID:2513186, PMID:8687384, PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | |
organism-modification
|
|
PR:000051276 |
tissue-type plasminogen activator N-glycosylated 27 (human)
|
hPLAT/NGlyco:27
|
"A tissue-type plasminogen activator (human) that has been N-glycosylated at the residue equivalent to Asn-152 of the amino acid sequence represented by UniProtKB:P00750-1, in which the glycan structure is represented by GlyTouCan:G96063MG. Example: UniProtKB:P00750-1, Asn-152, MOD:00160~GNO:G96063MG." [GlyGen:P00750-1, PMID:2226797, PMID:2513186, PMID:8687384, PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | |
organism-modification
|
|
PR:000051277 |
tissue-type plasminogen activator N-glycosylated 28 (human)
|
hPLAT/NGlyco:28
|
"A tissue-type plasminogen activator (human) that has been N-glycosylated at the residue equivalent to Asn-152 of the amino acid sequence represented by UniProtKB:P00750-1, in which the glycan structure is represented by GlyTouCan:G97832IV. Example: UniProtKB:P00750-1, Asn-152, MOD:00160~GNO:G97832IV." [GlyGen:P00750-1, PMID:2226797, PMID:2513186, PMID:8687384, PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | |
organism-modification
|
|
PR:000051278 |
tissue-type plasminogen activator N-glycosylated 29 (human)
|
hPLAT/NGlyco:29
|
"A tissue-type plasminogen activator (human) that has been N-glycosylated at the residue equivalent to Asn-219 of the amino acid sequence represented by UniProtKB:P00750-1, in which the glycan structure is represented by GlyTouCan:G00463XD. Example: UniProtKB:P00750-1, Asn-219, MOD:00160~GNO:G00463XD." [GlyGen:P00750-1, PMID:2514791, PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | |
organism-modification
|
|
PR:000051279 |
tissue-type plasminogen activator N-glycosylated 30 (human)
|
hPLAT/NGlyco:30
|
"A tissue-type plasminogen activator (human) that has been N-glycosylated at the residue equivalent to Asn-219 of the amino acid sequence represented by UniProtKB:P00750-1, in which the glycan structure is represented by GlyTouCan:G01769FS. Example: UniProtKB:P00750-1, Asn-219, MOD:00160~GNO:G01769FS." [GlyGen:P00750-1, PMID:2226797, PMID:2513186, PMID:8687384, PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | |
organism-modification
|
|
PR:000051280 |
tissue-type plasminogen activator N-glycosylated 31 (human)
|
hPLAT/NGlyco:31
|
"A tissue-type plasminogen activator (human) that has been N-glycosylated at the residue equivalent to Asn-219 of the amino acid sequence represented by UniProtKB:P00750-1, in which the glycan structure is represented by GlyTouCan:G02000AU. Example: UniProtKB:P00750-1, Asn-219, MOD:00160~GNO:G02000AU." [GlyGen:P00750-1, PMID:2514791, PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | |
organism-modification
|
|
PR:000051281 |
tissue-type plasminogen activator N-glycosylated 32 (human)
|
hPLAT/NGlyco:32
|
"A tissue-type plasminogen activator (human) that has been N-glycosylated at the residue equivalent to Asn-219 of the amino acid sequence represented by UniProtKB:P00750-1, in which the glycan structure is represented by GlyTouCan:G06772YH. Example: UniProtKB:P00750-1, Asn-219, MOD:00160~GNO:G06772YH." [GlyGen:P00750-1, PMID:2514791, PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | |
organism-modification
|
|
PR:000051282 |
tissue-type plasminogen activator N-glycosylated 33 (human)
|
hPLAT/NGlyco:33
|
"A tissue-type plasminogen activator (human) that has been N-glycosylated at the residue equivalent to Asn-219 of the amino acid sequence represented by UniProtKB:P00750-1, in which the glycan structure is represented by GlyTouCan:G09482NW. Example: UniProtKB:P00750-1, Asn-219, MOD:00160~GNO:G09482NW." [GlyGen:P00750-1, PMID:2226797, PMID:2513186, PMID:8687384, PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | |
organism-modification
|
|
PR:000051283 |
tissue-type plasminogen activator N-glycosylated 34 (human)
|
hPLAT/NGlyco:34
|
"A tissue-type plasminogen activator (human) that has been N-glycosylated at the residue equivalent to Asn-219 of the amino acid sequence represented by UniProtKB:P00750-1, in which the glycan structure is represented by GlyTouCan:G12398HZ. Example: UniProtKB:P00750-1, Asn-219, MOD:00160~GNO:G12398HZ." [GlyGen:P00750-1, PMID:2514791, PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | |
organism-modification
|
|
PR:000051284 |
tissue-type plasminogen activator N-glycosylated 35 (human)
|
hPLAT/NGlyco:35
|
"A tissue-type plasminogen activator (human) that has been N-glycosylated at the residue equivalent to Asn-219 of the amino acid sequence represented by UniProtKB:P00750-1, in which the glycan structure is represented by GlyTouCan:G13151XE. Example: UniProtKB:P00750-1, Asn-219, MOD:00160~GNO:G13151XE." [GlyGen:P00750-1, PMID:2226797, PMID:2513186, PMID:8687384, PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | |
organism-modification
|
|
PR:000051285 |
tissue-type plasminogen activator N-glycosylated 36 (human)
|
hPLAT/NGlyco:36
|
"A tissue-type plasminogen activator (human) that has been N-glycosylated at the residue equivalent to Asn-219 of the amino acid sequence represented by UniProtKB:P00750-1, in which the glycan structure is represented by GlyTouCan:G17689DH. Example: UniProtKB:P00750-1, Asn-219, MOD:00160~GNO:G17689DH." [GlyGen:P00750-1, PMID:2226797, PMID:2513186, PMID:8687384, PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | |
organism-modification
|
|
PR:000051286 |
tissue-type plasminogen activator N-glycosylated 37 (human)
|
hPLAT/NGlyco:37
|
"A tissue-type plasminogen activator (human) that has been N-glycosylated at the residue equivalent to Asn-219 of the amino acid sequence represented by UniProtKB:P00750-1, in which the glycan structure is represented by GlyTouCan:G21415RL. Example: UniProtKB:P00750-1, Asn-219, MOD:00160~GNO:G21415RL." [GlyGen:P00750-1, PMID:2226797, PMID:2513186, PMID:8687384, PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | |
organism-modification
|
|
PR:000051287 |
tissue-type plasminogen activator N-glycosylated 38 (human)
|
hPLAT/NGlyco:38
|
"A tissue-type plasminogen activator (human) that has been N-glycosylated at the residue equivalent to Asn-219 of the amino acid sequence represented by UniProtKB:P00750-1, in which the glycan structure is represented by GlyTouCan:G24440EI. Example: UniProtKB:P00750-1, Asn-219, MOD:00160~GNO:G24440EI." [GlyGen:P00750-1, PMID:2226797, PMID:2513186, PMID:8687384, PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | |
organism-modification
|
|
PR:000051288 |
tissue-type plasminogen activator N-glycosylated 39 (human)
|
hPLAT/NGlyco:39
|
"A tissue-type plasminogen activator (human) that has been N-glycosylated at the residue equivalent to Asn-219 of the amino acid sequence represented by UniProtKB:P00750-1, in which the glycan structure is represented by GlyTouCan:G24511TX. Example: UniProtKB:P00750-1, Asn-219, MOD:00160~GNO:G24511TX." [GlyGen:P00750-1, PMID:2226797, PMID:2513186, PMID:8687384, PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | |
organism-modification
|
|
PR:000051289 |
tissue-type plasminogen activator N-glycosylated 40 (human)
|
hPLAT/NGlyco:40
|
"A tissue-type plasminogen activator (human) that has been N-glycosylated at the residue equivalent to Asn-219 of the amino acid sequence represented by UniProtKB:P00750-1, in which the glycan structure is represented by GlyTouCan:G26076FX. Example: UniProtKB:P00750-1, Asn-219, MOD:00160~GNO:G26076FX." [GlyGen:P00750-1, PMID:2226797, PMID:2513186, PMID:8687384, PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | |
organism-modification
|
|
PR:000051290 |
tissue-type plasminogen activator N-glycosylated 41 (human)
|
hPLAT/NGlyco:41
|
"A tissue-type plasminogen activator (human) that has been N-glycosylated at the residue equivalent to Asn-219 of the amino acid sequence represented by UniProtKB:P00750-1, in which the glycan structure is represented by GlyTouCan:G29972ZX. Example: UniProtKB:P00750-1, Asn-219, MOD:00160~GNO:G29972ZX." [GlyGen:P00750-1, PMID:2514791, PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | |
organism-modification
|
|
PR:000051291 |
tissue-type plasminogen activator N-glycosylated 42 (human)
|
hPLAT/NGlyco:42
|
"A tissue-type plasminogen activator (human) that has been N-glycosylated at the residue equivalent to Asn-219 of the amino acid sequence represented by UniProtKB:P00750-1, in which the glycan structure is represented by GlyTouCan:G35808UX. Example: UniProtKB:P00750-1, Asn-219, MOD:00160~GNO:G35808UX." [GlyGen:P00750-1, PMID:2226797, PMID:2513186, PMID:8687384, PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | |
organism-modification
|
|
PR:000051292 |
tissue-type plasminogen activator N-glycosylated 43 (human)
|
hPLAT/NGlyco:43
|
"A tissue-type plasminogen activator (human) that has been N-glycosylated at the residue equivalent to Asn-219 of the amino acid sequence represented by UniProtKB:P00750-1, in which the glycan structure is represented by GlyTouCan:G37022BP. Example: UniProtKB:P00750-1, Asn-219, MOD:00160~GNO:G37022BP." [GlyGen:P00750-1, PMID:2226797, PMID:2513186, PMID:8687384, PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | |
organism-modification
|
|
PR:000051293 |
tissue-type plasminogen activator N-glycosylated 44 (human)
|
hPLAT/NGlyco:44
|
"A tissue-type plasminogen activator (human) that has been N-glycosylated at the residue equivalent to Asn-219 of the amino acid sequence represented by UniProtKB:P00750-1, in which the glycan structure is represented by GlyTouCan:G39172SO. Example: UniProtKB:P00750-1, Asn-219, MOD:00160~GNO:G39172SO." [GlyGen:P00750-1, PMID:2226797, PMID:2513186, PMID:8687384, PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | |
organism-modification
|
|
PR:000051294 |
tissue-type plasminogen activator N-glycosylated 45 (human)
|
hPLAT/NGlyco:45
|
"A tissue-type plasminogen activator (human) that has been N-glycosylated at the residue equivalent to Asn-219 of the amino acid sequence represented by UniProtKB:P00750-1, in which the glycan structure is represented by GlyTouCan:G40702WU. Example: UniProtKB:P00750-1, Asn-219, MOD:00160~GNO:G40702WU." [GlyGen:P00750-1, PMID:2226797, PMID:2513186, PMID:8687384, PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | |
organism-modification
|
|
PR:000051295 |
tissue-type plasminogen activator N-glycosylated 46 (human)
|
hPLAT/NGlyco:46
|
"A tissue-type plasminogen activator (human) that has been N-glycosylated at the residue equivalent to Asn-219 of the amino acid sequence represented by UniProtKB:P00750-1, in which the glycan structure is represented by GlyTouCan:G41304KE. Example: UniProtKB:P00750-1, Asn-219, MOD:00160~GNO:G41304KE." [GlyGen:P00750-1, PMID:2226797, PMID:2513186, PMID:8687384, PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | |
organism-modification
|
|
PR:000051296 |
tissue-type plasminogen activator N-glycosylated 47 (human)
|
hPLAT/NGlyco:47
|
"A tissue-type plasminogen activator (human) that has been N-glycosylated at the residue equivalent to Asn-219 of the amino acid sequence represented by UniProtKB:P00750-1, in which the glycan structure is represented by GlyTouCan:G43814TV. Example: UniProtKB:P00750-1, Asn-219, MOD:00160~GNO:G43814TV." [GlyGen:P00750-1, PMID:2514791, PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | |
organism-modification
|
|
PR:000051297 |
tissue-type plasminogen activator N-glycosylated 48 (human)
|
hPLAT/NGlyco:48
|
"A tissue-type plasminogen activator (human) that has been N-glycosylated at the residue equivalent to Asn-219 of the amino acid sequence represented by UniProtKB:P00750-1, in which the glycan structure is represented by GlyTouCan:G44533KV. Example: UniProtKB:P00750-1, Asn-219, MOD:00160~GNO:G44533KV." [GlyGen:P00750-1, PMID:2226797, PMID:2513186, PMID:8687384, PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | |
organism-modification
|
|
PR:000051298 |
tissue-type plasminogen activator N-glycosylated 49 (human)
|
hPLAT/NGlyco:49
|
"A tissue-type plasminogen activator (human) that has been N-glycosylated at the residue equivalent to Asn-219 of the amino acid sequence represented by UniProtKB:P00750-1, in which the glycan structure is represented by GlyTouCan:G44842OK. Example: UniProtKB:P00750-1, Asn-219, MOD:00160~GNO:G44842OK." [GlyGen:P00750-1, PMID:2514791, PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | |
organism-modification
|
|
PR:000051299 |
tissue-type plasminogen activator N-glycosylated 50 (human)
|
hPLAT/NGlyco:50
|
"A tissue-type plasminogen activator (human) that has been N-glycosylated at the residue equivalent to Asn-219 of the amino acid sequence represented by UniProtKB:P00750-1, in which the glycan structure is represented by GlyTouCan:G47108UC. Example: UniProtKB:P00750-1, Asn-219, MOD:00160~GNO:G47108UC." [GlyGen:P00750-1, PMID:2514791, PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | |
organism-modification
|
|
PR:000051300 |
tissue-type plasminogen activator N-glycosylated 51 (human)
|
hPLAT/NGlyco:51
|
"A tissue-type plasminogen activator (human) that has been N-glycosylated at the residue equivalent to Asn-219 of the amino acid sequence represented by UniProtKB:P00750-1, in which the glycan structure is represented by GlyTouCan:G48848IF. Example: UniProtKB:P00750-1, Asn-219, MOD:00160~GNO:G48848IF." [GlyGen:P00750-1, PMID:2226797, PMID:2513186, PMID:8687384, PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | |
organism-modification
|
|
PR:000051301 |
tissue-type plasminogen activator N-glycosylated 52 (human)
|
hPLAT/NGlyco:52
|
"A tissue-type plasminogen activator (human) that has been N-glycosylated at the residue equivalent to Asn-219 of the amino acid sequence represented by UniProtKB:P00750-1, in which the glycan structure is represented by GlyTouCan:G55220VL. Example: UniProtKB:P00750-1, Asn-219, MOD:00160~GNO:G55220VL." [GlyGen:P00750-1, PMID:2514791, PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | |
organism-modification
|
|
PR:000051302 |
tissue-type plasminogen activator N-glycosylated 53 (human)
|
hPLAT/NGlyco:53
|
"A tissue-type plasminogen activator (human) that has been N-glycosylated at the residue equivalent to Asn-219 of the amino acid sequence represented by UniProtKB:P00750-1, in which the glycan structure is represented by GlyTouCan:G58481XO. Example: UniProtKB:P00750-1, Asn-219, MOD:00160~GNO:G58481XO." [GlyGen:P00750-1, PMID:2226797, PMID:2513186, PMID:8687384, PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | |
organism-modification
|
|
PR:000051303 |
tissue-type plasminogen activator N-glycosylated 54 (human)
|
hPLAT/NGlyco:54
|
"A tissue-type plasminogen activator (human) that has been N-glycosylated at the residue equivalent to Asn-219 of the amino acid sequence represented by UniProtKB:P00750-1, in which the glycan structure is represented by GlyTouCan:G62765SF. Example: UniProtKB:P00750-1, Asn-219, MOD:00160~GNO:G62765SF." [GlyGen:P00750-1, PMID:2226797, PMID:2513186, PMID:8687384, PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | |
organism-modification
|
|
PR:000051304 |
tissue-type plasminogen activator N-glycosylated 55 (human)
|
hPLAT/NGlyco:55
|
"A tissue-type plasminogen activator (human) that has been N-glycosylated at the residue equivalent to Asn-219 of the amino acid sequence represented by UniProtKB:P00750-1, in which the glycan structure is represented by GlyTouCan:G68668TB. Example: UniProtKB:P00750-1, Asn-219, MOD:00160~GNO:G68668TB." [GlyGen:P00750-1, PMID:2226797, PMID:2513186, PMID:8687384, PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | |
organism-modification
|
|
PR:000051305 |
tissue-type plasminogen activator N-glycosylated 56 (human)
|
hPLAT/NGlyco:56
|
"A tissue-type plasminogen activator (human) that has been N-glycosylated at the residue equivalent to Asn-219 of the amino acid sequence represented by UniProtKB:P00750-1, in which the glycan structure is represented by GlyTouCan:G68758PE. Example: UniProtKB:P00750-1, Asn-219, MOD:00160~GNO:G68758PE." [GlyGen:P00750-1, PMID:2226797, PMID:2513186, PMID:8687384, PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | |
organism-modification
|
|
PR:000051306 |
tissue-type plasminogen activator N-glycosylated 57 (human)
|
hPLAT/NGlyco:57
|
"A tissue-type plasminogen activator (human) that has been N-glycosylated at the residue equivalent to Asn-219 of the amino acid sequence represented by UniProtKB:P00750-1, in which the glycan structure is represented by GlyTouCan:G70511VE. Example: UniProtKB:P00750-1, Asn-219, MOD:00160~GNO:G70511VE." [GlyGen:P00750-1, PMID:2226797, PMID:2513186, PMID:8687384, PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | |
organism-modification
|
|
PR:000051307 |
tissue-type plasminogen activator N-glycosylated 58 (human)
|
hPLAT/NGlyco:58
|
"A tissue-type plasminogen activator (human) that has been N-glycosylated at the residue equivalent to Asn-219 of the amino acid sequence represented by UniProtKB:P00750-1, in which the glycan structure is represented by GlyTouCan:G77038WW. Example: UniProtKB:P00750-1, Asn-219, MOD:00160~GNO:G77038WW." [GlyGen:P00750-1, PMID:2226797, PMID:2513186, PMID:8687384, PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | |
organism-modification
|
|
PR:000051308 |
tissue-type plasminogen activator N-glycosylated 59 (human)
|
hPLAT/NGlyco:59
|
"A tissue-type plasminogen activator (human) that has been N-glycosylated at the residue equivalent to Asn-219 of the amino acid sequence represented by UniProtKB:P00750-1, in which the glycan structure is represented by GlyTouCan:G80966KZ. Example: UniProtKB:P00750-1, Asn-219, MOD:00160~GNO:G80966KZ." [GlyGen:P00750-1, PMID:2226797, PMID:2513186, PMID:8687384, PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | |
organism-modification
|
|
PR:000051309 |
tissue-type plasminogen activator N-glycosylated 60 (human)
|
hPLAT/NGlyco:60
|
"A tissue-type plasminogen activator (human) that has been N-glycosylated at the residue equivalent to Asn-219 of the amino acid sequence represented by UniProtKB:P00750-1, in which the glycan structure is represented by GlyTouCan:G82779CI. Example: UniProtKB:P00750-1, Asn-219, MOD:00160~GNO:G82779CI." [GlyGen:P00750-1, PMID:2514791, PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | |
organism-modification
|
|
PR:000051310 |
tissue-type plasminogen activator N-glycosylated 61 (human)
|
hPLAT/NGlyco:61
|
"A tissue-type plasminogen activator (human) that has been N-glycosylated at the residue equivalent to Asn-219 of the amino acid sequence represented by UniProtKB:P00750-1, in which the glycan structure is represented by GlyTouCan:G83161QT. Example: UniProtKB:P00750-1, Asn-219, MOD:00160~GNO:G83161QT." [GlyGen:P00750-1, PMID:2226797, PMID:2513186, PMID:8687384, PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | |
organism-modification
|
|
PR:000051311 |
tissue-type plasminogen activator N-glycosylated 62 (human)
|
hPLAT/NGlyco:62
|
"A tissue-type plasminogen activator (human) that has been N-glycosylated at the residue equivalent to Asn-219 of the amino acid sequence represented by UniProtKB:P00750-1, in which the glycan structure is represented by GlyTouCan:G83461WR. Example: UniProtKB:P00750-1, Asn-219, MOD:00160~GNO:G83461WR." [GlyGen:P00750-1, PMID:2226797, PMID:2513186, PMID:8687384, PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | |
organism-modification
|
|
PR:000051312 |
tissue-type plasminogen activator N-glycosylated 63 (human)
|
hPLAT/NGlyco:63
|
"A tissue-type plasminogen activator (human) that has been N-glycosylated at the residue equivalent to Asn-219 of the amino acid sequence represented by UniProtKB:P00750-1, in which the glycan structure is represented by GlyTouCan:G85542KD. Example: UniProtKB:P00750-1, Asn-219, MOD:00160~GNO:G85542KD." [GlyGen:P00750-1, PMID:2226797, PMID:2513186, PMID:8687384, PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | |
organism-modification
|
|
PR:000051313 |
tissue-type plasminogen activator N-glycosylated 64 (human)
|
hPLAT/NGlyco:64
|
"A tissue-type plasminogen activator (human) that has been N-glycosylated at the residue equivalent to Asn-219 of the amino acid sequence represented by UniProtKB:P00750-1, in which the glycan structure is represented by GlyTouCan:G88027AL. Example: UniProtKB:P00750-1, Asn-219, MOD:00160~GNO:G88027AL." [GlyGen:P00750-1, PMID:2226797, PMID:2513186, PMID:8687384, PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | |
organism-modification
|
|
PR:000051314 |
tissue-type plasminogen activator N-glycosylated 65 (human)
|
hPLAT/NGlyco:65
|
"A tissue-type plasminogen activator (human) that has been N-glycosylated at the residue equivalent to Asn-219 of the amino acid sequence represented by UniProtKB:P00750-1, in which the glycan structure is represented by GlyTouCan:G88417ED. Example: UniProtKB:P00750-1, Asn-219, MOD:00160~GNO:G88417ED." [GlyGen:P00750-1, PMID:2226797, PMID:2513186, PMID:8687384, PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | |
organism-modification
|
|
PR:000051315 |
tissue-type plasminogen activator N-glycosylated 66 (human)
|
hPLAT/NGlyco:66
|
"A tissue-type plasminogen activator (human) that has been N-glycosylated at the residue equivalent to Asn-219 of the amino acid sequence represented by UniProtKB:P00750-1, in which the glycan structure is represented by GlyTouCan:G88461FF. Example: UniProtKB:P00750-1, Asn-219, MOD:00160~GNO:G88461FF." [GlyGen:P00750-1, PMID:2226797, PMID:2513186, PMID:8687384, PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | |
organism-modification
|
|
PR:000051316 |
tissue-type plasminogen activator N-glycosylated 67 (human)
|
hPLAT/NGlyco:67
|
"A tissue-type plasminogen activator (human) that has been N-glycosylated at the residue equivalent to Asn-219 of the amino acid sequence represented by UniProtKB:P00750-1, in which the glycan structure is represented by GlyTouCan:G91413ZX. Example: UniProtKB:P00750-1, Asn-219, MOD:00160~GNO:G91413ZX." [GlyGen:P00750-1, PMID:2226797, PMID:2513186, PMID:8687384, PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | |
organism-modification
|
|
PR:000051317 |
tissue-type plasminogen activator N-glycosylated 68 (human)
|
hPLAT/NGlyco:68
|
"A tissue-type plasminogen activator (human) that has been N-glycosylated at the residue equivalent to Asn-219 of the amino acid sequence represented by UniProtKB:P00750-1, in which the glycan structure is represented by GlyTouCan:G91905FJ. Example: UniProtKB:P00750-1, Asn-219, MOD:00160~GNO:G91905FJ." [GlyGen:P00750-1, PMID:2226797, PMID:2513186, PMID:8687384, PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | |
organism-modification
|
|
PR:000051318 |
tissue-type plasminogen activator N-glycosylated 69 (human)
|
hPLAT/NGlyco:69
|
"A tissue-type plasminogen activator (human) that has been N-glycosylated at the residue equivalent to Asn-219 of the amino acid sequence represented by UniProtKB:P00750-1, in which the glycan structure is represented by GlyTouCan:G92570PJ. Example: UniProtKB:P00750-1, Asn-219, MOD:00160~GNO:G92570PJ." [GlyGen:P00750-1, PMID:2226797, PMID:2513186, PMID:8687384, PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | |
organism-modification
|
|
PR:000051319 |
tissue-type plasminogen activator N-glycosylated 70 (human)
|
hPLAT/NGlyco:70
|
"A tissue-type plasminogen activator (human) that has been N-glycosylated at the residue equivalent to Asn-219 of the amino acid sequence represented by UniProtKB:P00750-1, in which the glycan structure is represented by GlyTouCan:G92617LF. Example: UniProtKB:P00750-1, Asn-219, MOD:00160~GNO:G92617LF." [GlyGen:P00750-1, PMID:2514791, PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | |
organism-modification
|
|
PR:000051320 |
tissue-type plasminogen activator N-glycosylated 71 (human)
|
hPLAT/NGlyco:71
|
"A tissue-type plasminogen activator (human) that has been N-glycosylated at the residue equivalent to Asn-219 of the amino acid sequence represented by UniProtKB:P00750-1, in which the glycan structure is represented by GlyTouCan:G93860XO. Example: UniProtKB:P00750-1, Asn-219, MOD:00160~GNO:G93860XO." [GlyGen:P00750-1, PMID:2226797, PMID:2513186, PMID:8687384, PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | |
organism-modification
|
|
PR:000051321 |
tissue-type plasminogen activator N-glycosylated 72 (human)
|
hPLAT/NGlyco:72
|
"A tissue-type plasminogen activator (human) that has been N-glycosylated at the residue equivalent to Asn-219 of the amino acid sequence represented by UniProtKB:P00750-1, in which the glycan structure is represented by GlyTouCan:G94141FZ. Example: UniProtKB:P00750-1, Asn-219, MOD:00160~GNO:G94141FZ." [GlyGen:P00750-1, PMID:2226797, PMID:2513186, PMID:8687384, PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | |
organism-modification
|
|
PR:000051322 |
tissue-type plasminogen activator N-glycosylated 73 (human)
|
hPLAT/NGlyco:73
|
"A tissue-type plasminogen activator (human) that has been N-glycosylated at the residue equivalent to Asn-219 of the amino acid sequence represented by UniProtKB:P00750-1, in which the glycan structure is represented by GlyTouCan:G94531EZ. Example: UniProtKB:P00750-1, Asn-219, MOD:00160~GNO:G94531EZ." [GlyGen:P00750-1, PMID:2226797, PMID:2513186, PMID:8687384, PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | |
organism-modification
|
|
PR:000051323 |
tissue-type plasminogen activator N-glycosylated 74 (human)
|
hPLAT/NGlyco:74
|
"A tissue-type plasminogen activator (human) that has been N-glycosylated at the residue equivalent to Asn-219 of the amino acid sequence represented by UniProtKB:P00750-1, in which the glycan structure is represented by GlyTouCan:G95861KV. Example: UniProtKB:P00750-1, Asn-219, MOD:00160~GNO:G95861KV." [GlyGen:P00750-1, PMID:2226797, PMID:2513186, PMID:8687384, PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | |
organism-modification
|
|
PR:000051324 |
tissue-type plasminogen activator N-glycosylated 75 (human)
|
hPLAT/NGlyco:75
|
"A tissue-type plasminogen activator (human) that has been N-glycosylated at the residue equivalent to Asn-219 of the amino acid sequence represented by UniProtKB:P00750-1, in which the glycan structure is represented by GlyTouCan:G96063MG. Example: UniProtKB:P00750-1, Asn-219, MOD:00160~GNO:G96063MG." [GlyGen:P00750-1, PMID:2226797, PMID:2513186, PMID:8687384, PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | |
organism-modification
|
|
PR:000051325 |
tissue-type plasminogen activator N-glycosylated 76 (human)
|
hPLAT/NGlyco:76
|
"A tissue-type plasminogen activator (human) that has been N-glycosylated at the residue equivalent to Asn-219 of the amino acid sequence represented by UniProtKB:P00750-1, in which the glycan structure is represented by GlyTouCan:G97832IV. Example: UniProtKB:P00750-1, Asn-219, MOD:00160~GNO:G97832IV." [GlyGen:P00750-1, PMID:2226797, PMID:2513186, PMID:8687384, PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | |
organism-modification
|
|
PR:000051326 |
tissue-type plasminogen activator N-glycosylated 77 (human)
|
hPLAT/NGlyco:77
|
"A tissue-type plasminogen activator (human) that has been N-glycosylated at the residue equivalent to Asn-483 of the amino acid sequence represented by UniProtKB:P00750-1, in which the glycan structure is represented by GlyTouCan:G00463XD. Example: UniProtKB:P00750-1, Asn-483, MOD:00160~GNO:G00463XD." [GlyGen:P00750-1, PMID:2514791, PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | |
organism-modification
|
|
PR:000051327 |
tissue-type plasminogen activator N-glycosylated 78 (human)
|
hPLAT/NGlyco:78
|
"A tissue-type plasminogen activator (human) that has been N-glycosylated at the residue equivalent to Asn-483 of the amino acid sequence represented by UniProtKB:P00750-1, in which the glycan structure is represented by GlyTouCan:G01769FS. Example: UniProtKB:P00750-1, Asn-483, MOD:00160~GNO:G01769FS." [GlyGen:P00750-1, PMID:2226797, PMID:2513186, PMID:8687384, PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | |
organism-modification
|
|
PR:000051328 |
tissue-type plasminogen activator N-glycosylated 79 (human)
|
hPLAT/NGlyco:79
|
"A tissue-type plasminogen activator (human) that has been N-glycosylated at the residue equivalent to Asn-483 of the amino acid sequence represented by UniProtKB:P00750-1, in which the glycan structure is represented by GlyTouCan:G02000AU. Example: UniProtKB:P00750-1, Asn-483, MOD:00160~GNO:G02000AU." [GlyGen:P00750-1, PMID:2514791, PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | |
organism-modification
|
|
PR:000051329 |
tissue-type plasminogen activator N-glycosylated 80 (human)
|
hPLAT/NGlyco:80
|
"A tissue-type plasminogen activator (human) that has been N-glycosylated at the residue equivalent to Asn-483 of the amino acid sequence represented by UniProtKB:P00750-1, in which the glycan structure is represented by GlyTouCan:G06772YH. Example: UniProtKB:P00750-1, Asn-483, MOD:00160~GNO:G06772YH." [GlyGen:P00750-1, PMID:2514791, PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | |
organism-modification
|
|
PR:000051330 |
tissue-type plasminogen activator N-glycosylated 81 (human)
|
hPLAT/NGlyco:81
|
"A tissue-type plasminogen activator (human) that has been N-glycosylated at the residue equivalent to Asn-483 of the amino acid sequence represented by UniProtKB:P00750-1, in which the glycan structure is represented by GlyTouCan:G09482NW. Example: UniProtKB:P00750-1, Asn-483, MOD:00160~GNO:G09482NW." [GlyGen:P00750-1, PMID:2226797, PMID:2513186, PMID:8687384, PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | |
organism-modification
|
|
PR:000051331 |
tissue-type plasminogen activator N-glycosylated 82 (human)
|
hPLAT/NGlyco:82
|
"A tissue-type plasminogen activator (human) that has been N-glycosylated at the residue equivalent to Asn-483 of the amino acid sequence represented by UniProtKB:P00750-1, in which the glycan structure is represented by GlyTouCan:G12398HZ. Example: UniProtKB:P00750-1, Asn-483, MOD:00160~GNO:G12398HZ." [GlyGen:P00750-1, PMID:2514791, PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | |
organism-modification
|
|
PR:000051332 |
tissue-type plasminogen activator N-glycosylated 83 (human)
|
hPLAT/NGlyco:83
|
"A tissue-type plasminogen activator (human) that has been N-glycosylated at the residue equivalent to Asn-483 of the amino acid sequence represented by UniProtKB:P00750-1, in which the glycan structure is represented by GlyTouCan:G13151XE. Example: UniProtKB:P00750-1, Asn-483, MOD:00160~GNO:G13151XE." [GlyGen:P00750-1, PMID:2226797, PMID:2513186, PMID:8687384, PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | |
organism-modification
|
|
PR:000051333 |
tissue-type plasminogen activator N-glycosylated 84 (human)
|
hPLAT/NGlyco:84
|
"A tissue-type plasminogen activator (human) that has been N-glycosylated at the residue equivalent to Asn-483 of the amino acid sequence represented by UniProtKB:P00750-1, in which the glycan structure is represented by GlyTouCan:G21415RL. Example: UniProtKB:P00750-1, Asn-483, MOD:00160~GNO:G21415RL." [GlyGen:P00750-1, PMID:2226797, PMID:2513186, PMID:8687384, PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | |
organism-modification
|
|
PR:000051334 |
tissue-type plasminogen activator N-glycosylated 85 (human)
|
hPLAT/NGlyco:85
|
"A tissue-type plasminogen activator (human) that has been N-glycosylated at the residue equivalent to Asn-483 of the amino acid sequence represented by UniProtKB:P00750-1, in which the glycan structure is represented by GlyTouCan:G24440EI. Example: UniProtKB:P00750-1, Asn-483, MOD:00160~GNO:G24440EI." [GlyGen:P00750-1, PMID:2226797, PMID:2513186, PMID:8687384, PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | |
organism-modification
|
|
PR:000051335 |
tissue-type plasminogen activator N-glycosylated 86 (human)
|
hPLAT/NGlyco:86
|
"A tissue-type plasminogen activator (human) that has been N-glycosylated at the residue equivalent to Asn-483 of the amino acid sequence represented by UniProtKB:P00750-1, in which the glycan structure is represented by GlyTouCan:G29972ZX. Example: UniProtKB:P00750-1, Asn-483, MOD:00160~GNO:G29972ZX." [GlyGen:P00750-1, PMID:2514791, PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | |
organism-modification
|
|
PR:000051336 |
tissue-type plasminogen activator N-glycosylated 87 (human)
|
hPLAT/NGlyco:87
|
"A tissue-type plasminogen activator (human) that has been N-glycosylated at the residue equivalent to Asn-483 of the amino acid sequence represented by UniProtKB:P00750-1, in which the glycan structure is represented by GlyTouCan:G35808UX. Example: UniProtKB:P00750-1, Asn-483, MOD:00160~GNO:G35808UX." [GlyGen:P00750-1, PMID:2226797, PMID:2513186, PMID:8687384, PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | |
organism-modification
|
|
PR:000051337 |
tissue-type plasminogen activator N-glycosylated 88 (human)
|
hPLAT/NGlyco:88
|
"A tissue-type plasminogen activator (human) that has been N-glycosylated at the residue equivalent to Asn-483 of the amino acid sequence represented by UniProtKB:P00750-1, in which the glycan structure is represented by GlyTouCan:G40702WU. Example: UniProtKB:P00750-1, Asn-483, MOD:00160~GNO:G40702WU." [GlyGen:P00750-1, PMID:2226797, PMID:2513186, PMID:8687384, PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | |
organism-modification
|
|
PR:000051338 |
tissue-type plasminogen activator N-glycosylated 89 (human)
|
hPLAT/NGlyco:89
|
"A tissue-type plasminogen activator (human) that has been N-glycosylated at the residue equivalent to Asn-483 of the amino acid sequence represented by UniProtKB:P00750-1, in which the glycan structure is represented by GlyTouCan:G41304KE. Example: UniProtKB:P00750-1, Asn-483, MOD:00160~GNO:G41304KE." [GlyGen:P00750-1, PMID:2226797, PMID:2513186, PMID:8687384, PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | |
organism-modification
|
|
PR:000051339 |
tissue-type plasminogen activator N-glycosylated 90 (human)
|
hPLAT/NGlyco:90
|
"A tissue-type plasminogen activator (human) that has been N-glycosylated at the residue equivalent to Asn-483 of the amino acid sequence represented by UniProtKB:P00750-1, in which the glycan structure is represented by GlyTouCan:G43814TV. Example: UniProtKB:P00750-1, Asn-483, MOD:00160~GNO:G43814TV." [GlyGen:P00750-1, PMID:2514791, PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | |
organism-modification
|
|
PR:000051340 |
tissue-type plasminogen activator N-glycosylated 91 (human)
|
hPLAT/NGlyco:91
|
"A tissue-type plasminogen activator (human) that has been N-glycosylated at the residue equivalent to Asn-483 of the amino acid sequence represented by UniProtKB:P00750-1, in which the glycan structure is represented by GlyTouCan:G44533KV. Example: UniProtKB:P00750-1, Asn-483, MOD:00160~GNO:G44533KV." [GlyGen:P00750-1, PMID:2226797, PMID:2513186, PMID:8687384, PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | |
organism-modification
|
|
PR:000051341 |
tissue-type plasminogen activator N-glycosylated 92 (human)
|
hPLAT/NGlyco:92
|
"A tissue-type plasminogen activator (human) that has been N-glycosylated at the residue equivalent to Asn-483 of the amino acid sequence represented by UniProtKB:P00750-1, in which the glycan structure is represented by GlyTouCan:G44842OK. Example: UniProtKB:P00750-1, Asn-483, MOD:00160~GNO:G44842OK." [GlyGen:P00750-1, PMID:2514791, PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | |
organism-modification
|
|
PR:000051342 |
tissue-type plasminogen activator N-glycosylated 93 (human)
|
hPLAT/NGlyco:93
|
"A tissue-type plasminogen activator (human) that has been N-glycosylated at the residue equivalent to Asn-483 of the amino acid sequence represented by UniProtKB:P00750-1, in which the glycan structure is represented by GlyTouCan:G47108UC. Example: UniProtKB:P00750-1, Asn-483, MOD:00160~GNO:G47108UC." [GlyGen:P00750-1, PMID:2514791, PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | |
organism-modification
|
|
PR:000051343 |
tissue-type plasminogen activator N-glycosylated 94 (human)
|
hPLAT/NGlyco:94
|
"A tissue-type plasminogen activator (human) that has been N-glycosylated at the residue equivalent to Asn-483 of the amino acid sequence represented by UniProtKB:P00750-1, in which the glycan structure is represented by GlyTouCan:G48848IF. Example: UniProtKB:P00750-1, Asn-483, MOD:00160~GNO:G48848IF." [GlyGen:P00750-1, PMID:2226797, PMID:2513186, PMID:8687384, PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | |
organism-modification
|
|
PR:000051344 |
tissue-type plasminogen activator N-glycosylated 95 (human)
|
hPLAT/NGlyco:95
|
"A tissue-type plasminogen activator (human) that has been N-glycosylated at the residue equivalent to Asn-483 of the amino acid sequence represented by UniProtKB:P00750-1, in which the glycan structure is represented by GlyTouCan:G53854XZ. Example: UniProtKB:P00750-1, Asn-483, MOD:00160~GNO:G53854XZ." [GlyGen:P00750-1, PMID:2514791, PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | |
organism-modification
|
|
PR:000051345 |
tissue-type plasminogen activator N-glycosylated 96 (human)
|
hPLAT/NGlyco:96
|
"A tissue-type plasminogen activator (human) that has been N-glycosylated at the residue equivalent to Asn-483 of the amino acid sequence represented by UniProtKB:P00750-1, in which the glycan structure is represented by GlyTouCan:G55220VL. Example: UniProtKB:P00750-1, Asn-483, MOD:00160~GNO:G55220VL." [GlyGen:P00750-1, PMID:2514791, PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | |
organism-modification
|
|
PR:000051346 |
tissue-type plasminogen activator N-glycosylated 97 (human)
|
hPLAT/NGlyco:97
|
"A tissue-type plasminogen activator (human) that has been N-glycosylated at the residue equivalent to Asn-483 of the amino acid sequence represented by UniProtKB:P00750-1, in which the glycan structure is represented by GlyTouCan:G68668TB. Example: UniProtKB:P00750-1, Asn-483, MOD:00160~GNO:G68668TB." [GlyGen:P00750-1, PMID:2226797, PMID:2513186, PMID:8687384, PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | |
organism-modification
|
|
PR:000051347 |
tissue-type plasminogen activator N-glycosylated 98 (human)
|
hPLAT/NGlyco:98
|
"A tissue-type plasminogen activator (human) that has been N-glycosylated at the residue equivalent to Asn-483 of the amino acid sequence represented by UniProtKB:P00750-1, in which the glycan structure is represented by GlyTouCan:G68758PE. Example: UniProtKB:P00750-1, Asn-483, MOD:00160~GNO:G68758PE." [GlyGen:P00750-1, PMID:2226797, PMID:2513186, PMID:8687384, PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | |
organism-modification
|
|
PR:000051348 |
tissue-type plasminogen activator N-glycosylated 99 (human)
|
hPLAT/NGlyco:99
|
"A tissue-type plasminogen activator (human) that has been N-glycosylated at the residue equivalent to Asn-483 of the amino acid sequence represented by UniProtKB:P00750-1, in which the glycan structure is represented by GlyTouCan:G77038WW. Example: UniProtKB:P00750-1, Asn-483, MOD:00160~GNO:G77038WW." [GlyGen:P00750-1, PMID:2226797, PMID:2513186, PMID:8687384, PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | |
organism-modification
|
|
PR:000051349 |
tissue-type plasminogen activator N-glycosylated 100 (human)
|
hPLAT/NGlyco:100
|
"A tissue-type plasminogen activator (human) that has been N-glycosylated at the residue equivalent to Asn-483 of the amino acid sequence represented by UniProtKB:P00750-1, in which the glycan structure is represented by GlyTouCan:G77964WB. Example: UniProtKB:P00750-1, Asn-483, MOD:00160~GNO:G77964WB." [GlyGen:P00750-1, PMID:2514791, PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | |
organism-modification
|
|
PR:000051350 |
tissue-type plasminogen activator N-glycosylated 101 (human)
|
hPLAT/NGlyco:101
|
"A tissue-type plasminogen activator (human) that has been N-glycosylated at the residue equivalent to Asn-483 of the amino acid sequence represented by UniProtKB:P00750-1, in which the glycan structure is represented by GlyTouCan:G80966KZ. Example: UniProtKB:P00750-1, Asn-483, MOD:00160~GNO:G80966KZ." [GlyGen:P00750-1, PMID:2226797, PMID:2513186, PMID:8687384, PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | |
organism-modification
|
|
PR:000051351 |
tissue-type plasminogen activator N-glycosylated 102 (human)
|
hPLAT/NGlyco:102
|
"A tissue-type plasminogen activator (human) that has been N-glycosylated at the residue equivalent to Asn-483 of the amino acid sequence represented by UniProtKB:P00750-1, in which the glycan structure is represented by GlyTouCan:G82779CI. Example: UniProtKB:P00750-1, Asn-483, MOD:00160~GNO:G82779CI." [GlyGen:P00750-1, PMID:2514791, PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | |
organism-modification
|
|
PR:000051352 |
tissue-type plasminogen activator N-glycosylated 103 (human)
|
hPLAT/NGlyco:103
|
"A tissue-type plasminogen activator (human) that has been N-glycosylated at the residue equivalent to Asn-483 of the amino acid sequence represented by UniProtKB:P00750-1, in which the glycan structure is represented by GlyTouCan:G83161QT. Example: UniProtKB:P00750-1, Asn-483, MOD:00160~GNO:G83161QT." [GlyGen:P00750-1, PMID:2226797, PMID:2513186, PMID:8687384, PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | |
organism-modification
|
|
PR:000051353 |
tissue-type plasminogen activator N-glycosylated 104 (human)
|
hPLAT/NGlyco:104
|
"A tissue-type plasminogen activator (human) that has been N-glycosylated at the residue equivalent to Asn-483 of the amino acid sequence represented by UniProtKB:P00750-1, in which the glycan structure is represented by GlyTouCan:G83461WR. Example: UniProtKB:P00750-1, Asn-483, MOD:00160~GNO:G83461WR." [GlyGen:P00750-1, PMID:2226797, PMID:2513186, PMID:8687384, PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | |
organism-modification
|
|
PR:000051354 |
tissue-type plasminogen activator N-glycosylated 105 (human)
|
hPLAT/NGlyco:105
|
"A tissue-type plasminogen activator (human) that has been N-glycosylated at the residue equivalent to Asn-483 of the amino acid sequence represented by UniProtKB:P00750-1, in which the glycan structure is represented by GlyTouCan:G85542KD. Example: UniProtKB:P00750-1, Asn-483, MOD:00160~GNO:G85542KD." [GlyGen:P00750-1, PMID:2226797, PMID:2513186, PMID:8687384, PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | |
organism-modification
|
|
PR:000051355 |
tissue-type plasminogen activator N-glycosylated 106 (human)
|
hPLAT/NGlyco:106
|
"A tissue-type plasminogen activator (human) that has been N-glycosylated at the residue equivalent to Asn-483 of the amino acid sequence represented by UniProtKB:P00750-1, in which the glycan structure is represented by GlyTouCan:G88417ED. Example: UniProtKB:P00750-1, Asn-483, MOD:00160~GNO:G88417ED." [GlyGen:P00750-1, PMID:2226797, PMID:2513186, PMID:8687384, PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | |
organism-modification
|
|
PR:000051356 |
tissue-type plasminogen activator N-glycosylated 107 (human)
|
hPLAT/NGlyco:107
|
"A tissue-type plasminogen activator (human) that has been N-glycosylated at the residue equivalent to Asn-483 of the amino acid sequence represented by UniProtKB:P00750-1, in which the glycan structure is represented by GlyTouCan:G88461FF. Example: UniProtKB:P00750-1, Asn-483, MOD:00160~GNO:G88461FF." [GlyGen:P00750-1, PMID:2226797, PMID:2513186, PMID:8687384, PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | |
organism-modification
|
|
PR:000051357 |
tissue-type plasminogen activator N-glycosylated 108 (human)
|
hPLAT/NGlyco:108
|
"A tissue-type plasminogen activator (human) that has been N-glycosylated at the residue equivalent to Asn-483 of the amino acid sequence represented by UniProtKB:P00750-1, in which the glycan structure is represented by GlyTouCan:G92570PJ. Example: UniProtKB:P00750-1, Asn-483, MOD:00160~GNO:G92570PJ." [GlyGen:P00750-1, PMID:2226797, PMID:2513186, PMID:8687384, PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | |
organism-modification
|
|
PR:000051358 |
tissue-type plasminogen activator N-glycosylated 109 (human)
|
hPLAT/NGlyco:109
|
"A tissue-type plasminogen activator (human) that has been N-glycosylated at the residue equivalent to Asn-483 of the amino acid sequence represented by UniProtKB:P00750-1, in which the glycan structure is represented by GlyTouCan:G92617LF. Example: UniProtKB:P00750-1, Asn-483, MOD:00160~GNO:G92617LF." [GlyGen:P00750-1, PMID:2514791, PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | |
organism-modification
|
|
PR:000051359 |
tissue-type plasminogen activator N-glycosylated 110 (human)
|
hPLAT/NGlyco:110
|
"A tissue-type plasminogen activator (human) that has been N-glycosylated at the residue equivalent to Asn-483 of the amino acid sequence represented by UniProtKB:P00750-1, in which the glycan structure is represented by GlyTouCan:G94141FZ. Example: UniProtKB:P00750-1, Asn-483, MOD:00160~GNO:G94141FZ." [GlyGen:P00750-1, PMID:2226797, PMID:2513186, PMID:8687384, PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | |
organism-modification
|
|
PR:000051360 |
tissue-type plasminogen activator N-glycosylated 111 (human)
|
hPLAT/NGlyco:111
|
"A tissue-type plasminogen activator (human) that has been N-glycosylated at the residue equivalent to Asn-483 of the amino acid sequence represented by UniProtKB:P00750-1, in which the glycan structure is represented by GlyTouCan:G95861KV. Example: UniProtKB:P00750-1, Asn-483, MOD:00160~GNO:G95861KV." [GlyGen:P00750-1, PMID:2226797, PMID:2513186, PMID:8687384, PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | |
organism-modification
|
|
PR:000051361 |
tissue-type plasminogen activator N-glycosylated 112 (human)
|
hPLAT/NGlyco:112
|
"A tissue-type plasminogen activator (human) that has been N-glycosylated at the residue equivalent to Asn-483 of the amino acid sequence represented by UniProtKB:P00750-1, in which the glycan structure is represented by GlyTouCan:G96063MG. Example: UniProtKB:P00750-1, Asn-483, MOD:00160~GNO:G96063MG." [GlyGen:P00750-1, PMID:2226797, PMID:2513186, PMID:8687384, PRO:DNx]
|
|
|
|
|
|
|
| | | | |
| | |
organism-modification
|
|
PR:000051362 |
tissue-type plasminogen activator N-glycosylated 113 (human)
|
hPLAT/NGlyco:113
|
"A tissue-type plasminogen activator (human) that has been N-glycosylated at the residue equivalent to Asn-483 of the amino acid sequence represented by UniProtKB:P00750-1, in which the glycan structure is represented by GlyTouCan:G97832IV. Example: UniProtKB:P00750-1, Asn-483, MOD:00160~GNO:G97832IV." [GlyGen:P00750-1, PMID:2226797, PMID:2513186, PMID:8687384, PRO:DNx]
|
|
|
|
|
|
